← Back to Browse
ProductDiagnostic Tests

Gastric Function Screening Series

China

A serological immunodiagnostic system for combined detection of PGI/II and G17 markers to evaluate gastric mucosa atrophy location and differentiate types of gastric atrophy. It features rapid detection, combined biomarkers, and quantitative analysis, approved for market launch in September 2022.

Manufactured by

Anhui Huibang Biological Engineering Co., Ltd.

China

National high-tech enterprise established in 2013, specializing in precision medicine diagnostics. Product lines include diabetic nephropathy tests, maternal and child health diagnostics, cardiovascular disease markers, tumor markers, and monoclonal antibody raw materials. Holds over 40 national patents with total investment of 450 million RMB.

View profile & products →

✦ Product-Specific Coverage

AI supplier coverage for this product

Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.

Generated for this product

AI-matched supplier coverage based on related product alternatives.

0
Relevant manufacturers
matched to this product
0
Relevant products analyzed
for supplier coverage
0
Sourcing countries
identified

Top sourcing countries

1China
39 relevant products
2United States
16 relevant products
3United Kingdom
12 relevant products
🔒

11 more sourcing countries available

Get free access to all sourcing countries identified for this product.

See all countries →

See the full supplier coverage for this product

Get free access to all relevant manufacturers, sourcing countries, and product alternatives.

Get Free Access →

Free for medical industry professionals.

AI-Matched Alternative Products

from other manufacturers

AI-Matched Alternative Products

from other manufacturers

3 of 93 closest product alternatives

93 products

90 more product alternatives available

Create a free account to compare more product alternatives and supplier options.

Get Free Access →

© 2026 Suplivia · Home · Browse Products